What Is Meda Dhatu?

In Ayurvedic medicine, the body is built from seven sequential tissues — the Sapta Dhatus. Each tissue nourishes the next, forming a cascade from the most refined plasma through to reproductive tissue. Meda Dhatu — the fourth Dhatu — is the fat tissue, and its Sanskrit root means "to lubricate." Its healthy function provides internal lubrication, thermal insulation, cushioning for organs, hormonal balance, and the metabolic fuel reserves the body draws upon during fasting or exertion. Critically, Meda also nourishes the fifth tissue, Asthi Dhatu (bone), meaning its disruption reverberates through the entire dhatu sequence downstream.

When Meda Dhatu is healthy — governed by balanced Medo Agni, the metabolic fire of fat tissue — the body stores and releases fat appropriately, skin is neither too dry nor too oily, joints move freely, and emotional stability is maintained. Ayurveda recognised that disturbed Meda produces Meda Dushti: contaminated, dysfunctional fat tissue blocked by Ama (accumulated metabolic toxins), leading to a category of disease it called Meda Pradoshaja Vikara — conditions arising directly from fat tissue dysfunction.

How Insulin Resistance Disrupts Meda Dhatu

Modern metabolic science maps almost precisely onto this ancient framework. When insulin resistance develops, fat cells lose their ability to respond correctly to insulin signals. Rather than storing and releasing fat in an orderly way, adipose tissue — Meda Dhatu — becomes dysfunctional: it floods the bloodstream with excess free fatty acids, fails to produce the protective hormone adiponectin, and begins releasing inflammatory proteins. This is Meda Dushti described in biochemical terms.

The consequences do not stay local to the fat tissue. The liver — the organ most directly downstream of this fat overflow — receives the greatest burden. Excess fatty acids delivered from dysfunctional fat tissue accumulate in liver cells, triggering a process the liver was never designed to manage at scale. The result is MASLD — Metabolic dysfunction-Associated Steatotic Liver Disease, formerly called fatty liver disease.

MASLD: Not Just a Liver Problem

Once fat accumulates in the liver, the consequences extend well beyond liver function itself. The liver is the body's central metabolic hub — responsible for regulating blood sugar, producing proteins that govern clotting and immunity, clearing hormones, metabolising drugs, and producing bile for digestion. When it becomes inflamed and fat-laden, all of these functions degrade simultaneously.

In the body: The inflamed liver releases inflammatory proteins into the bloodstream, raising cardiovascular risk, accelerating arterial damage, and contributing to insulin resistance in muscle tissue — worsening the original problem. Blood sugar regulation deteriorates as the liver overproduces glucose. Cholesterol ratios shift unfavourably.

In the brain: The liver plays a central role in producing the building blocks for dopamine and serotonin. As MASLD progresses, this capacity is impaired. Simultaneously, inflammatory proteins released by the inflamed liver cross the blood-brain barrier and suppress the enzymes responsible for neurotransmitter production — contributing to the low mood, reduced motivation and cognitive fog that many people with fatty liver disease report, often without connecting it to metabolic health at all.

In the gut: The gut-liver axis — the two-way communication channel between gut bacteria and the liver — is disrupted. A less healthy liver produces altered bile, which changes the environment of the gut, reducing populations of beneficial bacteria and further impairing the production of dopamine precursors manufactured in the gut lining.

Ayurveda recognised this systemic reach: disturbed Meda Dhatu disrupts the formation of Asthi (bone), Majja (marrow and nervous tissue) and ultimately Shukra (reproductive tissue) — a cascade that modern research on the systemic consequences of MASLD is now confirming through entirely different methods.

The critical insight from both traditions is the same: address the root cause — insulin resistance — and Meda Dhatu restores its healthy function, liver fat resolves, and the downstream cascade reverses. MASLD is not a liver disease that happens to coexist with insulin resistance. It is insulin resistance expressed in the liver — and therefore fully addressable by removing the metabolic cause.